Assyro AI

FDA Orange Book · active-ingredient family

Ciclopirox

Ciclopirox is approved as 5 brand and 27 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:LOPROX · NDA 021159

5

Brand (NDA)

27

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · cream, gel, shampoo, solution, suspension

ProductApplicantApplicationTEApproved
LOPROXRLDBAUSCHNDA 021159Feb 28, 2003
PENLACRLDVALEANT BERMUDANDA 021022Dec 17, 1999
CICLOPIROXRLDALVOGENNDA 020519Jul 21, 1997
LOPROXRLDEUROFARMANDA 019824ABDec 30, 1988
LOPROXRLDEUROFARMANDA 018748ABDec 30, 1982

Generic (ANDA) products (27)

ProductApplicantApplicationTEApproved
CICLOPIROXENCUBEANDA 209975ATApr 05, 2018
CICLOPIROXGLENMARK PHARMSANDA 091595ABFeb 29, 2012
CICLOPIROXSUN PHARMA CANADAANDA 090269ATFeb 23, 2011
CICLOPIROXCOSETTE PHARMS NCANDA 078463ABDec 20, 2010
CICLOPIROXFOUGERA PHARMSANDA 090146ATMay 25, 2010
CICLOPIROXEPIC PHARMA LLCANDA 078975Feb 17, 2010
CICLOPIROXPADAGIS USANDA 078594ATFeb 16, 2010
CICLOPIROXACTAVIS MID ATLANTICANDA 090490ATNov 24, 2009
CICLOPIROXGLENMARK PHARMSANDA 090273ABNov 10, 2009
CICLOPIROXPADAGIS USANDA 078266ABJan 07, 2009
CICLOPIROXFOUGERA PHARMSANDA 077896ABJun 10, 2008
CICLOPIROXACELLAANDA 078172ATSep 18, 2007
CICLOPIROXCHARTWELL RXANDA 078046ATSep 18, 2007
CICLOPIROXCOSETTE PHARMS NCANDA 078233Sep 18, 2007
CICLOPIROXENCUBEANDA 077687ATSep 18, 2007
CICLOPIROXHIKMAANDA 078270Sep 18, 2007
CICLOPIROXMYLAN PHARMS INCANDA 078567Sep 18, 2007
CICLOPIROXPADAGIS USANDA 077623ATSep 18, 2007
CICLOPIROXRISINGANDA 078124ATSep 18, 2007
CICLOPIROXTARO PHARM INDSANDA 078144Sep 18, 2007
CICLOPIROXTEVA PHARMSANDA 078079Sep 18, 2007
CICLOPIROXPADAGIS ISRAELANDA 077676ABDec 15, 2006
CICLOPIROXPADAGIS ISRAELANDA 077364ABMar 03, 2006
CICLOPIROXSUN PHARMA CANADAANDA 077092Aug 10, 2005
CICLOPIROXSUN PHARMA CANADAANDA 076790ABApr 12, 2005
CICLOPIROXFOUGERA PHARMSANDA 076435ABDec 29, 2004
CICLOPIROXFOUGERA PHARMSANDA 076422ABAug 06, 2004

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ciclopirox — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.